Breaking News Instant updates and real-time market news.

ZIP

ZipRecruiter

$25.00 /

+1.46 (+6.20%)

06:11
07/01/21
07/01
06:11
07/01/21
06:11

ZipRecruiter initiated with an Overweight at Barclays

Barclays analyst Trevor Young initiated coverage of ZipRecruiter with an Overweight rating and $30 price target. ZipRecruiter is a leading online recruiting marketplace that is gaining share in the $13B U.S. online recruiting industry, Young tells investors in a research note. The analyst says the company is differentiated from online peers by its artificial intelligence-based matching, "resulting in faster/better quality candidate recommendations and faster time-to-hire, alleviating key pain points for employer-customers." He's constructive on the fundamental story and ZipRecruiter's ability to win share.

  • 26

    May

ZIP ZipRecruiter
$25.00 /

+1.46 (+6.20%)

06/21/21
Fly Intel: Top five analyst initiations
06/21/21 JPMorgan
ZipRecruiter initiated with a Neutral at JPMorgan
06/21/21 Evercore ISI
Evercore ISI starts 'differentiated' ZipRecruiter at Outperform
06/21/21 Raymond James
ZipRecruiter initiated with a Strong Buy at Raymond James

TODAY'S FREE FLY STORIES

Earnings
Meredith reports Q1 EPS 51c, consensus 68c » 07:08
10/28/21
10/28
07:08
10/28/21
07:08
MDP

Meredith

$58.31 /

-0.095 (-0.16%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MDP Meredith
$58.31 /

-0.095 (-0.16%)

MDP Meredith
$58.31 /

-0.095 (-0.16%)

10/08/21 Citi
Meredith downgraded to Neutral from Buy at Citi
10/07/21 Benchmark
IAC price target raised to $218 from $200 at Benchmark
10/07/21 Piper Sandler
IAC acquisition of Meredith done at 'reasonable' price, says Piper Sandler
09/27/21 Benchmark
IAC could be 'big winner' if Meredith rumor true, says Benchmark
MDP Meredith
$58.31 /

-0.095 (-0.16%)

MDP Meredith
$58.31 /

-0.095 (-0.16%)

MDP Meredith
$58.31 /

-0.095 (-0.16%)

Earnings
Huntington Bancshares reports Q3 adjusted EPS 35c, consensus 32c » 07:07
10/28/21
10/28
07:07
10/28/21
07:07
HBAN

Huntington Bancshares

$15.98 /

-0.5 (-3.03%)

Reports Q3 revenue $1.7B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HBAN Huntington Bancshares
$15.98 /

-0.5 (-3.03%)

HBAN Huntington Bancshares
$15.98 /

-0.5 (-3.03%)

09/07/21 Baird
Huntington Bancshares weakness a buying opportunity, says Baird
08/18/21 Goldman Sachs
Huntington Bancshares reinstated with a Buy at Goldman Sachs
07/06/21 Keefe Bruyette
Huntington Bancshares assumed with a Market Perform at Keefe Bruyette
06/23/21 Raymond James
Huntington Bancshares upgraded to Strong Buy from Outperform at Raymond James
HBAN Huntington Bancshares
$15.98 /

-0.5 (-3.03%)

HBAN Huntington Bancshares
$15.98 /

-0.5 (-3.03%)

Recommendations
Nurix Therapeutics price target raised to $49 from $46 at Baird » 07:07
10/28/21
10/28
07:07
10/28/21
07:07
NRIX

Nurix Therapeutics

$33.88 /

+4.99 (+17.27%)

Baird analyst Joel Beatty…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NRIX Nurix Therapeutics
$33.88 /

+4.99 (+17.27%)

NRIX Nurix Therapeutics
$33.88 /

+4.99 (+17.27%)

10/27/21 SVB Leerink
Nurix Therapeutics price target raised to $64 from $50 at SVB Leerink
10/27/21 Piper Sandler
Nurix Phase I data 'incredibly encouraging,' says Piper Sandler
10/14/21 SVB Leerink
Nurix Therapeutics initiated with an Outperform at SVB Leerink
06/03/21 Baird
Nurix Therapeutics transferred with Outperform at Baird
NRIX Nurix Therapeutics
$33.88 /

+4.99 (+17.27%)

  • 05
    Mar
Earnings
Altria Group narrows FY21 adjusted EPS view to $4.58-$4.62 from $4.49-$4.62 » 07:07
10/28/21
10/28
07:07
10/28/21
07:07
MO

Altria Group

$47.49 /

-0.625 (-1.30%)

Consensus $4.62. Altria…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MO Altria Group
$47.49 /

-0.625 (-1.30%)

MO Altria Group
$47.49 /

-0.625 (-1.30%)

10/19/21 Jefferies
Altria move for control of Juul 'even more likely and necessary,' says Jefferies
10/14/21 Morgan Stanley
Odds rising of Altria monetizing AB InBev stake, says Morgan Stanley
09/30/21 Stifel
Stifel surprised and 'disappointed' by ITC banning IQOS importation
09/30/21 BofA
Altria, Philip Morris still well positioned despite IQOS 'setback,' says BofA
MO Altria Group
$47.49 /

-0.625 (-1.30%)

MO Altria Group
$47.49 /

-0.625 (-1.30%)

MO Altria Group
$47.49 /

-0.625 (-1.30%)

MO Altria Group
$47.49 /

-0.625 (-1.30%)

Earnings
Evelo Biosciences reports Q3 EPS (63c), consensus (54c) » 07:07
10/28/21
10/28
07:07
10/28/21
07:07
EVLO

Evelo Biosciences

$8.07 /

-0.16 (-1.94%)

"This was a pivotal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EVLO Evelo Biosciences
$8.07 /

-0.16 (-1.94%)

EVLO Evelo Biosciences
$8.07 /

-0.16 (-1.94%)

10/19/21 Morgan Stanley
Evelo Biosciences assumed with an Equal Weight at Morgan Stanley
09/28/21 Jefferies
Evelo Biosciences price target lowered to $14 from $18 at Jefferies
07/30/21 Chardan
Evelo Biosciences price target lowered to $12 from $15 at Chardan
07/22/21 JMP Securities
Seres trial news 'disappointing,' but an isolated story, says JMP
EVLO Evelo Biosciences
$8.07 /

-0.16 (-1.94%)

  • 29
    Jan
EVLO Evelo Biosciences
$8.07 /

-0.16 (-1.94%)

Earnings
A.O. Smith reports Q3 EPS 82c, consensus 68c » 07:06
10/28/21
10/28
07:06
10/28/21
07:06
AOS

A.O. Smith

$63.98 /

-1.285 (-1.97%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AOS A.O. Smith
$63.98 /

-1.285 (-1.97%)

AOS A.O. Smith
$63.98 /

-1.285 (-1.97%)

10/05/21
Fly Intel: Top five analyst upgrades
10/05/21 Baird
Baird upgrades A.O. Smith on catalysts and compelling valuation
10/05/21 Baird
A.O. Smith upgraded to Outperform from Neutral at Baird
04/05/21
Fly Intel: Top five analyst downgrades
AOS A.O. Smith
$63.98 /

-1.285 (-1.97%)

Earnings
Molson Coors sees FY21 net sales revenue: mid-single digit increase versus 2020 » 07:06
10/28/21
10/28
07:06
10/28/21
07:06
TAP

Molson Coors

$43.66 /

+0.105 (+0.24%)

Sees Underlying EBITDA:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TAP Molson Coors
$43.66 /

+0.105 (+0.24%)

TAP Molson Coors
$43.66 /

+0.105 (+0.24%)

10/20/21 Alliance Global Partners
Alliance Global Partners cuts Hexo target to C$5 following executive changes
10/18/21 Deutsche Bank
Molson Coors price target lowered to $48 from $50 at Deutsche Bank
09/16/21 Barclays
Molson Coors price target lowered to $48 from $53 at Barclays
06/21/21 Guggenheim
Boston Beer named a 'Best Idea' at Guggenheim
TAP Molson Coors
$43.66 /

+0.105 (+0.24%)

TAP Molson Coors
$43.66 /

+0.105 (+0.24%)

TAP Molson Coors
$43.66 /

+0.105 (+0.24%)

Earnings
Ultralife reports Q3 EPS (4c), one est. 8c » 07:06
10/28/21
10/28
07:06
10/28/21
07:06
ULBI

Ultralife

$6.95 /

-0.05 (-0.71%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ULBI Ultralife
$6.95 /

-0.05 (-0.71%)

ULBI Ultralife
$6.95 /

-0.05 (-0.71%)

03/26/21 Benchmark
Benchmark starts 'small form battery play' Ultralife at Buy
03/26/21 Benchmark
Ultralife initiated with a Buy at Benchmark
ULBI Ultralife
$6.95 /

-0.05 (-0.71%)

ULBI Ultralife
$6.95 /

-0.05 (-0.71%)

Earnings
Sonic Automotive reports Q3 cont-op EPS $1.96, consensus $1.92 » 07:05
10/28/21
10/28
07:05
10/28/21
07:05
SAH

Sonic Automotive

$49.42 /

-0.79 (-1.57%)

Reports Q3 revenue $3.1B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAH Sonic Automotive
$49.42 /

-0.79 (-1.57%)

SAH Sonic Automotive
$49.42 /

-0.79 (-1.57%)

09/17/21 JPMorgan
Sonic's EchoPark has 'significant untapped value,' says JPMorgan
01/15/21 JPMorgan
Sonic Automotive upgraded to Overweight with $55 target at JPMorgan
01/15/21 JPMorgan
Sonic Automotive upgraded to Overweight from Neutral at JPMorgan
12/07/20 Morgan Stanley
Morgan Stanley upgrades Asbury, downgrades Lithia in auto dealer rating shake-up
SAH Sonic Automotive
$49.42 /

-0.79 (-1.57%)

Earnings
Genocea expects cash, cash equivalents to fund operations into Q3 of 2022 » 07:05
10/28/21
10/28
07:05
10/28/21
07:05
GNCA

Genocea

$1.67 /

-0.1 (-5.65%)

As of September 30, 2021,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GNCA Genocea
$1.67 /

-0.1 (-5.65%)

GNCA Genocea
$1.67 /

-0.1 (-5.65%)

Earnings
Sirius XM raises FY21 revenue view to $8.65B from $8.55B » 07:05
10/28/21
10/28
07:05
10/28/21
07:05
SIRI

Sirius XM

$5.97 /

-0.08 (-1.32%)

Consensus is $8.59B. The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIRI Sirius XM
$5.97 /

-0.08 (-1.32%)

SIRI Sirius XM
$5.97 /

-0.08 (-1.32%)

10/19/21 Pivotal Research
Sirius XM price target lowered to $8 from $8.25 at Pivotal Research
10/08/21
Fly Intel: Top five analyst downgrades
10/08/21 JPMorgan
JPMorgan downgrades Sirius XM on slowing car sales, higher costs
10/08/21 JPMorgan
Sirius XM downgraded to Neutral from Overweight at JPMorgan
SIRI Sirius XM
$5.97 /

-0.08 (-1.32%)

SIRI Sirius XM
$5.97 /

-0.08 (-1.32%)

SIRI Sirius XM
$5.97 /

-0.08 (-1.32%)

Recommendations
Masco price target raised to $82 from $78 at Baird » 07:04
10/28/21
10/28
07:04
10/28/21
07:04
MAS

Masco

$64.26 /

+3.13 (+5.12%)

Baird analyst Timothy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAS Masco
$64.26 /

+3.13 (+5.12%)

MAS Masco
$64.26 /

+3.13 (+5.12%)

06:58 Today RBC Capital
Masco price target raised to $77 from $73 at RBC Capital
10/04/21 Loop Capital
Masco price target lowered to $60 from $63 at Loop Capital
07/15/21 Wells Fargo
Masco initiated with an Overweight at Wells Fargo
07/15/21 Barclays
Masco price target lowered to $62 from $64 at Barclays
MAS Masco
$64.26 /

+3.13 (+5.12%)

MAS Masco
$64.26 /

+3.13 (+5.12%)

MAS Masco
$64.26 /

+3.13 (+5.12%)

Hot Stocks
Altria Group expands share repurchase program to $3.5B from $2B » 07:04
10/28/21
10/28
07:04
10/28/21
07:04
MO

Altria Group

$47.49 /

-0.625 (-1.30%)

Billy Gifford,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MO Altria Group
$47.49 /

-0.625 (-1.30%)

MO Altria Group
$47.49 /

-0.625 (-1.30%)

10/19/21 Jefferies
Altria move for control of Juul 'even more likely and necessary,' says Jefferies
10/14/21 Morgan Stanley
Odds rising of Altria monetizing AB InBev stake, says Morgan Stanley
09/30/21 Stifel
Stifel surprised and 'disappointed' by ITC banning IQOS importation
09/30/21 BofA
Altria, Philip Morris still well positioned despite IQOS 'setback,' says BofA
MO Altria Group
$47.49 /

-0.625 (-1.30%)

MO Altria Group
$47.49 /

-0.625 (-1.30%)

MO Altria Group
$47.49 /

-0.625 (-1.30%)

MO Altria Group
$47.49 /

-0.625 (-1.30%)

Hot Stocks
Genocea reports Q3 EPS (5c), consensus (20c) » 07:04
10/28/21
10/28
07:04
10/28/21
07:04
GNCA

Genocea

$1.67 /

-0.1 (-5.65%)

"We continue to make…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GNCA Genocea
$1.67 /

-0.1 (-5.65%)

GNCA Genocea
$1.67 /

-0.1 (-5.65%)

Hot Stocks
Keurig Dr Pepper sees management leverage ratio at or below 3.0x at year-end  07:04
10/28/21
10/28
07:04
10/28/21
07:04
KDP

Keurig Dr Pepper

$34.20 /

-0.37 (-1.07%)

 
ShowHide Related Items >><<
KDP Keurig Dr Pepper
$34.20 /

-0.37 (-1.07%)

KDP Keurig Dr Pepper
$34.20 /

-0.37 (-1.07%)

10/04/21 JPMorgan
Keurig Dr Pepper should be bought on weakness, says JPMorgan
09/20/21 Deutsche Bank
Keurig Dr Pepper price target raised to $36 from $35 at Deutsche Bank
06/29/21
Fly Intel: Top five analyst upgrades
06/29/21 Wells Fargo
Wells Fargo upgrades Keurig Dr Pepper on carbonated beverage tailwind
KDP Keurig Dr Pepper
$34.20 /

-0.37 (-1.07%)

  • 08
    Jun
  • 17
    Nov
KDP Keurig Dr Pepper
$34.20 /

-0.37 (-1.07%)

KDP Keurig Dr Pepper
$34.20 /

-0.37 (-1.07%)

Earnings
Molson Coors reports Q3 EPS $1.75, consensus $1.53 » 07:04
10/28/21
10/28
07:04
10/28/21
07:04
TAP

Molson Coors

$43.66 /

+0.105 (+0.24%)

Reports Q revenue $2.82B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TAP Molson Coors
$43.66 /

+0.105 (+0.24%)

TAP Molson Coors
$43.66 /

+0.105 (+0.24%)

10/20/21 Alliance Global Partners
Alliance Global Partners cuts Hexo target to C$5 following executive changes
10/18/21 Deutsche Bank
Molson Coors price target lowered to $48 from $50 at Deutsche Bank
09/16/21 Barclays
Molson Coors price target lowered to $48 from $53 at Barclays
06/21/21 Guggenheim
Boston Beer named a 'Best Idea' at Guggenheim
TAP Molson Coors
$43.66 /

+0.105 (+0.24%)

TAP Molson Coors
$43.66 /

+0.105 (+0.24%)

TAP Molson Coors
$43.66 /

+0.105 (+0.24%)

Earnings
Kirby expects Q4 earnings to sequentially improve » 07:04
10/28/21
10/28
07:04
10/28/21
07:04
KEX

Kirby

$55.60 /

-0.155 (-0.28%)

Commenting on the 2021…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KEX Kirby
$55.60 /

-0.155 (-0.28%)

KEX Kirby
$55.60 /

-0.155 (-0.28%)

10/12/21 Stifel
Kirby upgraded to Buy from Hold at Stifel
05/07/21 Gabelli
Kirby downgraded to Hold at Gabelli on decelerating earnings growth after 2023
05/07/21 Gabelli
Kirby downgraded to Hold from Buy at Gabelli
11/18/20 BofA
Kirby upgraded to Buy at BofA on refinery utilization increase potential
KEX Kirby
$55.60 /

-0.155 (-0.28%)

Earnings
Sirius XM reports Q3 EPS 8c, consensus 7c » 07:04
10/28/21
10/28
07:04
10/28/21
07:04
SIRI

Sirius XM

$5.97 /

-0.08 (-1.32%)

Reports Q3 revenue $2.2B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIRI Sirius XM
$5.97 /

-0.08 (-1.32%)

SIRI Sirius XM
$5.97 /

-0.08 (-1.32%)

10/19/21 Pivotal Research
Sirius XM price target lowered to $8 from $8.25 at Pivotal Research
10/08/21
Fly Intel: Top five analyst downgrades
10/08/21 JPMorgan
JPMorgan downgrades Sirius XM on slowing car sales, higher costs
10/08/21 JPMorgan
Sirius XM downgraded to Neutral from Overweight at JPMorgan
SIRI Sirius XM
$5.97 /

-0.08 (-1.32%)

SIRI Sirius XM
$5.97 /

-0.08 (-1.32%)

SIRI Sirius XM
$5.97 /

-0.08 (-1.32%)

Earnings
Altria Group reports Q3 adjusted EPS $1.22, consensus $1.26 » 07:04
10/28/21
10/28
07:04
10/28/21
07:04
MO

Altria Group

$47.49 /

-0.625 (-1.30%)

Reports Q3 revenues net…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MO Altria Group
$47.49 /

-0.625 (-1.30%)

MO Altria Group
$47.49 /

-0.625 (-1.30%)

10/19/21 Jefferies
Altria move for control of Juul 'even more likely and necessary,' says Jefferies
10/14/21 Morgan Stanley
Odds rising of Altria monetizing AB InBev stake, says Morgan Stanley
09/30/21 Stifel
Stifel surprised and 'disappointed' by ITC banning IQOS importation
09/30/21 BofA
Altria, Philip Morris still well positioned despite IQOS 'setback,' says BofA
MO Altria Group
$47.49 /

-0.625 (-1.30%)

MO Altria Group
$47.49 /

-0.625 (-1.30%)

MO Altria Group
$47.49 /

-0.625 (-1.30%)

MO Altria Group
$47.49 /

-0.625 (-1.30%)

Earnings
Comcast reports Q3 adjusted EPS 87c, consensus 75c » 07:03
10/28/21
10/28
07:03
10/28/21
07:03
CMCSA

Comcast

$52.46 /

-1.29 (-2.40%)

, CMCSK

Comcast

$58.00 /

+ (+0.00%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMCSA Comcast
$52.46 /

-1.29 (-2.40%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$52.46 /

-1.29 (-2.40%)

10/13/21 Morgan Stanley
Morgan Stanley says Comcast dropping network a modest near-term negative for MSG
10/12/21 Deutsche Bank
Comcast price target lowered to $64 from $68 at Deutsche Bank
10/11/21
Fly Intel: Top five analyst downgrades
10/11/21 Raymond James
Comcast downgraded to Market Perform from Outperform at Raymond James
CMCSK Comcast
$58.00 /

+ (+0.00%)

02/23/21 Credit Suisse
SeaWorld price target raised to $52 from $34 at Credit Suisse
CMCSA Comcast
$52.46 /

-1.29 (-2.40%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$52.46 /

-1.29 (-2.40%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$52.46 /

-1.29 (-2.40%)

CMCSK Comcast
$58.00 /

+ (+0.00%)

CMCSA Comcast
$52.46 /

-1.29 (-2.40%)

Earnings
LabCorp raises FY21 adjusted EPS view to $26-$28 from $25-$26 » 07:03
10/28/21
10/28
07:03
10/28/21
07:03
LH

LabCorp

$280.41 /

-3.6 (-1.27%)

Consensus is $24.16.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LH LabCorp
$280.41 /

-3.6 (-1.27%)

LH LabCorp
$280.41 /

-3.6 (-1.27%)

10/19/21 Citi
Citi opens 'Positive Catalyst watches' on Quest, LabCorp
08/20/21 Credit Suisse
LabCorp price target raised to $336 from $295 at Credit Suisse
08/19/21 Mizuho
LabCorp price target raised to $332 from $318 at Mizuho
07/30/21 Truist
LabCorp price target raised to $350 from $330 at Truist
LH LabCorp
$280.41 /

-3.6 (-1.27%)

Earnings
Kirby reports Q3 adjusted EPS 17c, consensus 25c » 07:03
10/28/21
10/28
07:03
10/28/21
07:03
KEX

Kirby

$55.60 /

-0.155 (-0.28%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KEX Kirby
$55.60 /

-0.155 (-0.28%)

KEX Kirby
$55.60 /

-0.155 (-0.28%)

10/12/21 Stifel
Kirby upgraded to Buy from Hold at Stifel
05/07/21 Gabelli
Kirby downgraded to Hold at Gabelli on decelerating earnings growth after 2023
05/07/21 Gabelli
Kirby downgraded to Hold from Buy at Gabelli
11/18/20 BofA
Kirby upgraded to Buy at BofA on refinery utilization increase potential
KEX Kirby
$55.60 /

-0.155 (-0.28%)

Earnings
LabCorp reports Q3 adjusted EPS $6.82, consensus $4.92 » 07:02
10/28/21
10/28
07:02
10/28/21
07:02
LH

LabCorp

$280.41 /

-3.6 (-1.27%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LH LabCorp
$280.41 /

-3.6 (-1.27%)

LH LabCorp
$280.41 /

-3.6 (-1.27%)

10/19/21 Citi
Citi opens 'Positive Catalyst watches' on Quest, LabCorp
08/20/21 Credit Suisse
LabCorp price target raised to $336 from $295 at Credit Suisse
08/19/21 Mizuho
LabCorp price target raised to $332 from $318 at Mizuho
07/30/21 Truist
LabCorp price target raised to $350 from $330 at Truist
LH LabCorp
$280.41 /

-3.6 (-1.27%)

Recommendations
Boot Barn price target raised to $125 from $105 at Baird » 07:02
10/28/21
10/28
07:02
10/28/21
07:02
BOOT

Boot Barn

$100.35 /

-0.425 (-0.42%)

Baird analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BOOT Boot Barn
$100.35 /

-0.425 (-0.42%)

BOOT Boot Barn
$100.35 /

-0.425 (-0.42%)

06:10 Today Citi
Boot Barn price target raised to $126 from $120 at Citi
10/22/21 UBS
Boot Barn price target raised to $109 from $94 at UBS
10/20/21 Cowen
Boot Barn price target raised to $110 from $97 at Cowen
10/20/21 Citi
Boot Barn price target raised to $120 from $110 at Citi
BOOT Boot Barn
$100.35 /

-0.425 (-0.42%)

BOOT Boot Barn
$100.35 /

-0.425 (-0.42%)

BOOT Boot Barn
$100.35 /

-0.425 (-0.42%)

Earnings
Keurig Dr Pepper backs FY21 adjusted EPS growth view 13%-15% » 07:02
10/28/21
10/28
07:02
10/28/21
07:02
KDP

Keurig Dr Pepper

$34.20 /

-0.37 (-1.07%)

FY21 consensus $1.60. …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KDP Keurig Dr Pepper
$34.20 /

-0.37 (-1.07%)

KDP Keurig Dr Pepper
$34.20 /

-0.37 (-1.07%)

10/04/21 JPMorgan
Keurig Dr Pepper should be bought on weakness, says JPMorgan
09/20/21 Deutsche Bank
Keurig Dr Pepper price target raised to $36 from $35 at Deutsche Bank
06/29/21
Fly Intel: Top five analyst upgrades
06/29/21 Wells Fargo
Wells Fargo upgrades Keurig Dr Pepper on carbonated beverage tailwind
KDP Keurig Dr Pepper
$34.20 /

-0.37 (-1.07%)

  • 08
    Jun
  • 17
    Nov
KDP Keurig Dr Pepper
$34.20 /

-0.37 (-1.07%)

KDP Keurig Dr Pepper
$34.20 /

-0.37 (-1.07%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.